Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Depreciation and Depletion: 2022-2023

Historic Depreciation and Depletion for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Dec 2023 value amounting to $287,000.

  • Orchestra BioMed Holdings' Depreciation and Depletion rose 7.04% to $76,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $296,000, marking a year-over-year increase of 4.23%. This contributed to the annual value of $287,000 for FY2023, which is 29.28% up from last year.
  • As of FY2023, Orchestra BioMed Holdings' Depreciation and Depletion stood at $287,000, which was up 29.28% from $222,000 recorded in FY2022.
  • Orchestra BioMed Holdings' Depreciation and Depletion's 5-year high stood at $287,000 during FY2023, with a 5-year trough of $222,000 in FY2022.
  • Over the past 2 years, Orchestra BioMed Holdings' median Depreciation and Depletion value was $254,500 (recorded in 2022), while the average stood at $254,500.
  • Data for Orchestra BioMed Holdings' Depreciation and Depletion shows a peak YoY grew of 29.28% (in 2023) over the last 5 years.
  • Over the past 2 years, Orchestra BioMed Holdings' Depreciation and Depletion (Yearly) stood at $222,000 in 2022, then grew by 29.28% to $287,000 in 2023.